It is also possible that ER stress may serve as potential biomarkers to predict GVHD onset, in that elevated expressions of GRP78 and CHOP in patient biopsies were shown to correlate with the severity of GVHD (87). This evidence concerns the gene HSPA5 and graft versus host disease.